Health Economics; Economics of Ageing; Health Policy Analysis
Thomas Rapp, PhD, is a professor of economics at Université Paris Cité, specialized in health economics, ageing economics, and health policy analysis. He is the director of the AgingUP! Excellency Chaire at Fondation Université Paris Cité. He is a former Harkness fellow in health policy and practice at Harvard (2015-2016) and health economist at the OECD (2017-2019). His research is published in leading peer-reviewed scientific journals (Health Economics, Medical Care, Social Science and Medicine, JAMA open, etc.), book chapters etc. Since 2016, he has been associate editor of the Value in Health Journal. In 2015, he created (and led until 2018) a masters’ degree in health economics at Sorbonne University in Abu Dhabi.
For the past 10 years, he has been participating in several research grants (sponsored by the French Agence Nationale de la Recherche, the Commonwealth Fund of New York, the European Commission’s Innovative Medicines Initiative program, AXA mécénat etc.) as principal investigator, co-PI, or work package leader. He has been an invited professor at Harvard, Columbia, and Università Cattolica del Sacro Cuore di Roma.
ORCID : 0000-0003-0837-9302
Full Curriculum: CV THOMAS RAPP_eng
RESEARCH (last 10 years)
2014-2020: Sarcopenia and physical frailty in older people: multi-component treatment strategies, Innovative Medicines Initiative (IMI), European Commission, co-PI: leader of the health economics work package (PI Prof. Bernabei). Work package objectives: explore the economic consequences of frailty in Europe, and evaluate the cost-effectiveness of the SPRINT-T intervention. http://www.imi.europa.eu/content/sprintt
2015-2018: Improving detection and access to care for frail elderly people in France, Caisse Nationale d’Assurance Vieillesse, Co-PI with Nicolas Sirven (€192,000). Objective: develop a quantitative assessment of public measures to improve frail elders’ access to care.
2015-2022: Economic impact of HAS guidelines adherence for French type II diabetes patients, Foundation MGEN for Public Health Research, co-PI (18-mth salary for a postdoc fellow at MGEN, co-mentored with Dr. Sevilla-Dedieu). Our objective is to explore the impact of good adherence to HAS’ guidelines for diabetes follow-up on various economic outcomes.
2020-2022: Economic impact of HAS guidelines adherence for French type II diabetes patients. Foundation MGEN for Public Health Research, co-PI (18-mth salary for a postdoc fellow at MGEN, co-mentored with Dr. Sevilla-Dedieu). Our objective is to explore the impact of good adherence to HAS’ guidelines for diabetes follow-up on various economic outcomes.
2020-2022: Exploring the impact of LTC reforms on disability risks in Europe, ANR-18-IDEX-0001 Université de Paris 2019, Co-PI with M. Avendano (Kings’ College London).
OTHER RESPONSABILITIES (last 10 years)
2011-2015 National University Council (Economics Section: 05) French Ministry of Research
2011-2015 Scientific Board France Alzheimer Association
2011-2016 Permanent Scientific Advisory Board Janssen Pharmaceuticals
2016-2020 Scientific Board – MEMENTO Cohort French Alzheimer Plan
2011-2020 Scientific Committee for the Evaluation of the PATHOS and AGGIR pricing Tools French Ministry of Health
2021-2022 Expert in health policy France Expertise
EDUCATION
2001: Bachelor’s degree Economics Université Toulouse Capitole
2002: Maîtrise Economics Université Toulouse Capitole
2003: Master’s degree Economics Université Paris Dauphine
2007: Ph.D. Economics Université Paris Dauphine
2016: Accreditation to supervise research (HDR) Economics Université Rennes 1